Published in EMBO Rep on February 01, 2001
The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J (2004) 2.15
Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta (2007) 1.64
Raf-1 regulates Rho signaling and cell migration. J Cell Biol (2005) 1.58
The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol (2003) 1.44
Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem (2009) 1.18
Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation. J Cell Biol (2002) 1.11
Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. Proc Natl Acad Sci U S A (2005) 1.09
E7 abolishes raf-induced arrest via mislocalization of p21(Cip1). Mol Cell Biol (2002) 1.09
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations. Dis Model Mech (2010) 1.04
Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Front Biol (Beijing) (2014) 0.90
Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype. Mol Cell Biol (2003) 0.90
The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression. PLoS One (2011) 0.79
Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery. Oncogene (2012) 0.79
Effects of disulfiram on apoptosis in PANC-1 human pancreatic cancer cell line. Res Pharm Sci (2015) 0.79
Comparison of the anti-cancer effect of Disulfiram and 5-Aza-CdR on pancreatic cancer cell line PANC-1. Adv Biomed Res (2014) 0.77
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41
Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell (1980) 8.10
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature (2000) 4.90
Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol (1997) 4.36
The ARF/p53 pathway. Curr Opin Genet Dev (2000) 4.13
PML is induced by oncogenic ras and promotes premature senescence. Genes Dev (2000) 3.35
High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol (1997) 2.89
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell (1993) 2.62
The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev (1996) 2.61
Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell (1995) 2.24
Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev (1997) 1.88
An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature (1986) 1.86
Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J (1988) 1.80
p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci U S A (1999) 1.79
The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis--thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res (1994) 1.76
Malignant transformation of mouse primary keratinocytes by Harvey sarcoma virus and its modulation by surrounding normal cells. Proc Natl Acad Sci U S A (1988) 1.66
Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. Proc Natl Acad Sci U S A (1988) 1.62
Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals. Cancer Res (1983) 1.43
Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis. Oncogene (1999) 1.23
Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Cancer Res (1999) 1.19
Integration of positive and negative growth signals during ras pathway activation in vivo. Curr Opin Genet Dev (2000) 1.04
p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene. Cancer Res (1994) 0.99
Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes. Exp Dermatol (2000) 0.95
Comparison of flow and laser scanning cytometry for the assay of cell proliferation in human solid tumors. Cytometry (1998) 0.81
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res (1990) 20.53
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
5'-Terminal sequences of eucaryotic mRNA can be cloned with high efficiency. Nucleic Acids Res (1981) 8.10
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (1985) 7.07
Cellular oncogenes and multistep carcinogenesis. Science (1983) 6.52
Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell (1993) 5.86
Stem cell patterning and fate in human epidermis. Cell (1995) 5.22
A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res (1990) 4.79
Regulation of development and differentiation by the extracellular matrix. Development (1993) 4.13
Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell (1993) 4.10
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (1992) 3.43
The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. Development (1999) 3.31
c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol (2001) 3.22
High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol (1997) 2.89
Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol (1986) 2.86
Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature (1989) 2.77
Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr Biol (2000) 2.58
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J (1993) 2.57
An in situ transgenic enzyme marker for the midgestation mouse embryo and the visualization of inner cell mass clones during early organogenesis. Development (1989) 2.55
Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature (1982) 2.54
Stem cells: the generation and maintenance of cellular diversity. Development (1989) 2.54
Multiple mRNAs are generated from the chicken lysozyme gene. Cell (1981) 2.46
Stratification and terminal differentiation of cultured epidermal cells. Nature (1982) 2.44
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell (1989) 2.42
Negative autoregulation of c-myc transcription. EMBO J (1990) 2.38
c-Myc promotes differentiation of human epidermal stem cells. Genes Dev (1997) 2.37
Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J (1999) 2.31
Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev (1994) 2.29
Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell (1995) 2.24
The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell (2000) 2.22
Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell (1990) 2.20
Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol (1981) 2.14
Signaling via beta1 integrins and mitogen-activated protein kinase determines human epidermal stem cell fate in vitro. Proc Natl Acad Sci U S A (1999) 2.06
Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol (1994) 2.05
Calcium-induced reorganization of desmosomal components in cultured human keratinocytes. J Cell Biol (1984) 2.00
Selective migration of terminally differentiating cells from the basal layer of cultured human epidermis. J Cell Biol (1984) 1.93
Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules. Proc Natl Acad Sci U S A (1991) 1.91
beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development (1999) 1.89
Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A (1990) 1.89
Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev (1997) 1.88
Cloning of chicken lysozyme structural gene sequences synthesized in vitro. Nucleic Acids Res (1978) 1.80
Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J (1988) 1.80
Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J (1993) 1.78
Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes. J Cell Sci (1996) 1.74
Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene (1992) 1.73
Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab Invest (2000) 1.66
Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med (1997) 1.63
DNA amplification is rare in normal human cells. Proc Natl Acad Sci U S A (1990) 1.63
Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest (1992) 1.58
Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol (1983) 1.58
Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res (1993) 1.53
Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem (2001) 1.50
Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol (1997) 1.50
Regulation of cell surface beta 1 integrin levels during keratinocyte terminal differentiation. J Cell Biol (1995) 1.48
Synthesis of ds-cDNA involving addition of dCMP tails to allow cloning of 5'-terminal m RNA sequences. Methods Enzymol (1983) 1.46
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol (1991) 1.42
Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J Invest Dermatol (1987) 1.42
Two subpopulations of differentiated chondrocytes identified with a monoclonal antibody to keratan sulfate. J Cell Biol (1985) 1.41
Integrin expression during human epidermal development in vivo and in vitro. Development (1991) 1.41
Evidence-based guidelines for treatment of bacterial respiratory tract infections in the era of antibiotic resistance. Manag Care Interface (2001) 1.40
The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev (1997) 1.39
Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium. Curr Biol (2000) 1.39
Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol (1990) 1.38
Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes. Arch Dermatol Res (1987) 1.36
Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene (1997) 1.35
Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol (1996) 1.35
Indian hedgehog and beta-catenin signaling: role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad Sci U S A (2003) 1.33
A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest (2001) 1.31
Influence of beta1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha3beta1, but not alpha2beta1, suppresses malignant conversion. Cancer Res (2001) 1.28
Regulation by vitamin A of envelope cross-linking in cultured keratinocytes derived from different human epithelia. Mol Cell Biol (1982) 1.27
beta1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms. Mol Biol Cell (2000) 1.26
Deduced amino acid sequence from the bovine oxytocin-neurophysin I precursor cDNA. Nature (1983) 1.25
Analysis of cultured keratinocytes from a transgenic mouse model of psoriasis: effects of suprabasal integrin expression on keratinocyte adhesion, proliferation and terminal differentiation. Exp Dermatol (1999) 1.24
Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol (1997) 1.24
Subcellular distribution of envoplakin and periplakin: insights into their role as precursors of the epidermal cornified envelope. J Cell Biol (2000) 1.23
Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond B Biol Sci (1994) 1.23
Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J Oral Pathol Med (1997) 1.21
Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun (1996) 1.20
Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning. Dev Dyn (2001) 1.19
Transcriptional and post-translational regulation of beta 1 integrin expression during keratinocyte terminal differentiation. J Biol Chem (1992) 1.19
Differentiation of embryonal stem cells into keratinocytes: comparison of wild-type and beta 1 integrin-deficient cells. Dev Biol (1996) 1.17
Chicken lysozyme gene contains several intervening sequences. Proc Natl Acad Sci U S A (1979) 1.17
Calcium-induced changes in distribution and solubility of cadherins, integrins and their associated cytoplasmic proteins in human keratinocytes. Cell Adhes Commun (1995) 1.15
Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol (1999) 1.14
Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes. Oncogene (1995) 1.13
Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene (2001) 1.13
Biochemical specificity of Xenopus notochord. Differentiation (1985) 1.13
Production of scatter factor by ndk, a strain of epithelial cells, and inhibition of scatter factor activity by suramin. J Cell Sci (1991) 1.12
Optimised retroviral infection of human epidermal keratinocytes: long-term expression of transduced integrin gene following grafting on to SCID mice. Gene Ther (1998) 1.11
Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet (1993) 1.10
Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol (1998) 1.10
Immortalization and transformation are associated with specific alterations in choline metabolism. Cancer Res (1996) 1.08
C-MYC: evidence for multiple regulatory functions. Semin Cancer Biol (1990) 1.06
Structure of the lysozyme gene and expression in the oviduct and macrophages. Haematol Blood Transfus (1981) 1.06
Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells. J Cell Biol (1989) 1.05
Characterisation of eight monoclonal antibodies to involucrin. Hybridoma (1992) 1.03
Depressive illness in childhood presenting as severe headache. Am J Dis Child (1970) 1.02
Gene targeting of envoplakin, a cytoskeletal linker protein and precursor of the epidermal cornified envelope. Mol Cell Biol (2001) 1.01